ALHC (NASDAQ: ALHC) director Christopher Joyce files Form 144 to sell RSU shares

Rhea-AI Filing Summary

Alignment Healthcare, Inc. (ALHC) director Christopher Joyce filed a Form 144 reporting proposed sales of 32,500 shares and 18,818 shares that were acquired upon RSU vesting on 03/13/2024 and 03/13/2025, respectively. The filing notes prior open-market dispositions under a 10b5-1 Sales Plan, showing sales of 10,611 shares on 01/02/2026 for $212,590.32 and 16,187 shares on 12/29/2025 for $303,388.01.

Insights

Corporate Governance Analyst

Director filed resale notice and cites a 10b5-1 plan; prior recent dispositions are shown.

The filing lists RSU-vested shares from 03/13/2024 (32,500 shares) and 03/13/2025 (18,818 shares) as the securities proposed for sale. It separately documents recent sales of 10,611 and 16,187 shares on 01/02/2026 and 12/29/2025.

Timing and cash-flow treatment are routine for a Form 144; the excerpt indicates transactions under a 10b5-1 Sales Plan, which suggests prearranged dispositions. Subsequent filings will show actual execution details and remaining holdings.

Equity Compensation Specialist

Shares being offered arise from vested RSUs granted under the 2021 Equity Incentive Plan.

The filing explicitly ties the proposed sales to RSU vesting dates on 03/13/2024 and 03/13/2025, indicating these are compensation-originated shares. The amounts are listed as 32,500 and 18,818 shares respectively.

These are routine compensation-related holdings being moved into the market; the excerpt shows past executed sales amounts and proceeds but does not state remaining post-transaction holdings.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	E-Trade Finance PO Box 101600 Arlington VA 22210-4600	27592	468787.51	204296493	03/18/2026	Nasdaq Stock Market

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	03/13/2024	The Common Stock was acquired through the vesting of restricted stock units granted on 03/13/2024 under the Issuer's 2021 Equity Incentive Plan	Alignment Healthcare, Inc. (Issuer)			32500	03/13/2024	n/a
Common Stock	03/13/2025	The Common Stock was acquired through the vesting of restricted stock units granted on 03/13/2025 under the Issuer's 2021 Equity Incentive Plan	Alignment Healthcare, Inc. (Issuer)			18818	03/13/2025	n/a

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales Plan for Christopher Joyce 1100 W. Town & Country Road, Suite 1600 Orange CA 92868	Common Stock	01/02/2026	10611	212590.32
Christopher Joyce 1100 W. Town & Country Road, Suite 1600 Orange CA 92868	Common Stock	12/29/2025	16187	303388.01

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did Christopher Joyce report in the Form 144 for ALHC?

The Form 144 reports proposed sales of 32,500 and 18,818 shares tied to RSU vesting on 03/13/2024 and 03/13/2025. The filing also lists recent executed sales under a 10b5-1 plan.

Were any sales already executed by Christopher Joyce before this Form 144?

Yes. The excerpt shows executed sales of 10,611 shares on 01/02/2026 for $212,590.32 and 16,187 shares on 12/29/2025 for $303,388.01, documented as past dispositions.

Why are the shares listed as acquired on specific dates in the Form 144?

The filing states the shares were acquired through the vesting of restricted stock units granted under the Issuer's 2021 Equity Incentive Plan on 03/13/2024 and 03/13/2025, which is the source of the reported shares.

Does the Form 144 indicate the sales are part of a Rule 10b5-1 plan?

Yes. The filing references a 10b5-1 Sales Plan for Christopher Joyce, indicating at least some dispositions were made pursuant to a prearranged trading plan.

How much cash did prior sales generate according to the filing excerpt?

The excerpt shows proceeds of $212,590.32 from the 01/02/2026 sale of 10,611 shares and $303,388.01 from the 12/29/2025 sale of 16,187 shares.